Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic-specific rates.
about
Drugs for preventing red blood cell dehydration in people with sickle cell diseasePhytomedicines (medicines derived from plants) for sickle cell diseaseProphylactic antibiotics for preventing pneumococcal infection in children with sickle cell diseaseProphylactic antibiotics for preventing pneumococcal infection in children with sickle cell diseasePhytomedicines (medicines derived from plants) for sickle cell diseaseDrugs for preventing red blood cell dehydration in people with sickle cell diseaseBlood transfusion for preventing primary and secondary stroke in people with sickle cell diseasePreoperative blood transfusions for sickle cell diseasePhytomedicines (medicines derived from plants) for sickle cell diseaseDrugs for preventing red blood cell dehydration in people with sickle cell diseasePiracetam for reducing the incidence of sickle cell disease crisesLong-term effect of prospective detection of high genetic risk on couples' reproductive life: data for thalassaemia.Hemoglobinopathies: a longitudinal study over four decades.Organisation and cost-effectiveness of antenatal haemoglobinopathy screening and follow up in a community-based programme.Preoperative blood transfusions for sickle cell disease.Blood transfusion for preventing stroke in people with sickle cell disease.The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype)Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.Therapeutic challenges in childhood sickle cell disease. Part 2: a problem-orientated approach.Respect, trust, and the management of sickle cell disease pain in hospital: comparative analysis of concern-raising behaviors, preliminary model, and agenda for international collaborative research to inform practice.Characterizing emergency admissions of patients with sickle cell crisis in NHS brent: observational study.Patients' views on improving sickle cell disease management in primary care: focus group discussion.Epidemiology of haemoglobin disorders in Europe: an overview.Left ventricular dysfunction in sickle cell disease: the value of an electrocardiographic marker of increased risk of arrhythmia.Global epidemiology of haemoglobin disorders and derived service indicators.Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry.Sickle cell disease and pregnancy outcomes: a study of the community-based hospital in a tribal block of Gujarat, IndiaHaemoglobin C Promotes Distinct Membrane Properties in Heterozygous HbSC red Cells.An electronic infrastructure for research and treatment of the thalassemias and other hemoglobinopathies: the Euro-mediterranean ITHANET project.The lives of adults over 30 living with sickle cell disorder.Dental arch morphological and dimensional characteristics in Jordanian children and young adults with beta-thalassaemia major.The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom.Ethnicity of children with homozygous c.985A>G medium-chain acyl-CoA dehydrogenase deficiency: findings from screening approximately 1.1 million newborn infants.Treatments for priapism in boys and men with sickle cell disease.A retrospective observational study of pre-operative sickle cell screening.Ethnicity questions and antenatal screening for sickle cell/thalassaemia [EQUANS] in England: a randomised controlled trial of two questionnaires.Sickle cell disease
P2860
Q24186046-D725939F-66F7-4B11-9F8B-C31705FC4796Q24186614-EA1F4B2C-47F5-439E-B0C2-4FFF435ADEB5Q24188084-02EDCA82-66A6-4588-BB59-7292691DFA1DQ24200730-B00E5F5C-2317-4287-9127-F7DA571F46DBQ24201601-54A4151D-C530-4D8C-AC6B-BAD76678F5BDQ24202032-AE1224F3-61FD-406C-9C9E-A589B41646D1Q24202463-8000E7E9-C80F-4AA8-AA00-88F096CB25AEQ24203843-7E5BCAB2-E440-483F-92A5-0CA1577F67D6Q24234577-154B0430-4680-441D-A559-4D228D1C87DAQ24240777-14B8BD06-E91C-45BB-83B3-EBF2A0552BEAQ24245820-6D7B8AC1-C851-40A4-A02A-E589FB9C91ACQ30598214-0413F520-59D1-483B-B59C-A4EEB2A73D94Q33686883-4B0E4805-5DA1-4E8D-815D-6B2DE8D1F67DQ33888126-42D0E414-D997-4076-B704-A9E64C55A625Q34424247-05FC4B99-7D6E-4091-9FDA-D10B1DEB1B67Q34546913-104B5F90-898D-4E01-BB06-845D57E2FB4BQ34734929-5B0EC0EE-4E7F-4C26-AD95-4B2364560D14Q34758278-EAECC714-DDC6-442A-81AD-70B0016D1976Q35076607-ADEA10E1-A1FE-4E46-A98C-FE317C8F2828Q35601509-E78C2D45-8850-427A-BD1A-3CC418961B30Q36067803-D8B70776-B3F6-4FA9-BCF0-A87864EC4D3CQ36533733-A75255ED-53FD-499F-8750-68AB97A07797Q36762095-39D7F77F-078B-4674-99A4-6C6607B7E90FQ37073354-54444AD1-4110-46E0-86FB-752465D1107FQ37108897-E6C4C634-4D9A-4E2C-8BFC-AB17C94F182CQ37307614-8F9B4B96-D49C-42DE-AF15-F4102DEE39F9Q37597311-ABC740A1-F917-4554-B6D1-787B02F08BCFQ38255432-F2FB7757-81D3-47C1-9262-4FE28077F843Q38435210-A1BD420B-C836-44E3-8CE4-2FBF768940CFQ39288718-E42FA07B-CD6F-4249-8022-29FDAA3A51F2Q39711845-625026BA-805D-411F-90B2-FEB1A4058CCEQ44618194-A229EEFD-CE81-4A5D-BC2C-ABB22CDD1DE2Q46312678-85D51A52-B6C2-4F31-AA3C-F7C863736450Q46876025-90CF9B5A-F393-4FE5-87A9-E6884D327422Q49145290-43871415-BC05-43D7-9BDB-B77F0AE91767Q50113450-B7B7C4BD-D2F0-4691-B936-17ED75ED156BQ56771490-052CA27B-045D-4CEE-B22A-69571500F94B
P2860
Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic-specific rates.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Mapping the prevalence of sick ...... idating ethnic-specific rates.
@en
type
label
Mapping the prevalence of sick ...... idating ethnic-specific rates.
@en
prefLabel
Mapping the prevalence of sick ...... idating ethnic-specific rates.
@en
P2093
P2860
P1476
Mapping the prevalence of sick ...... lidating ethnic-specific rates
@en
P2093
P2860
P304
P356
10.1046/J.1365-2141.1999.01275.X
P407
P577
1999-03-01T00:00:00Z